Katarina Luptakova

Chief Tech/Sci/R&D Officer at XILIO THERAPEUTICS, INC.

Net worth: - $ as of 30/04/2024

Health Technology

Consumer Services

Katarina Luptakova active positions

Companies	Position	Start	End
XILIO THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/10/2022	-

Companies	Position	Start	End
TESARO INC	Chief Tech/Sci/R&D Officer	-	-
CONSTELLATION PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

University of Commenius

Doctorate Degree

International

United States	4
Slovakia	2

Operational

Chief Tech/Sci/R&D Officer	2
Corporate Officer/Principal	1
Doctorate Degree	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
XILIO THERAPEUTICS, INC.	Health Technology

Private companies	2
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA.	Health Technology
Tesaro, Inc. Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.	Health Technology

Private companies

Health Technology